Data protection Impressum

Life sciences

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

The Lausanne University Hospital (CHUV) strengthens its oncology network with the launch of a dedicated bladder cancer center offering personalized, high-level treatment and coordinated support.

CHUV opens new bladder cancer center combining advanced care and interdisciplinary expertise

16 June 2025

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

Bern-based medtech LEM Surgical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Dynamis Robotic Surgical System. The announcement marks a major regulatory milestone for the company and paves the way for the introduction of its next-generation spine surgery robot into U.S. hospitals.

LEM Surgical receives FDA clearance for its Dynamis Robotic Surgical System

26 May 2025

Lausanne-based biotech ReproNovo has secured USD 65 million to advance Phase 2 trials for novel therapies in male infertility and women’s reproductive health.

ReproNovo raises USD 65 million to advance trials in reproductive health

21 May 2025

Inaugurated in May 2025, the PULSE Innovation Center in Cheseaux-sur-Lausanne is emerging as a flagship site for life sciences and high-tech companies in Western Switzerland, offering modular infrastructure, shared services, and a unique environment for collaboration and growth.

PULSE, a new era for innovation in Western Switzerland

21 May 2025

Swiss Medical Network has become the first healthcare provider in Western Europe to join the prestigious Mayo Clinic Care Network. The collaboration strengthens Switzerland’s position as a hub for advanced medical innovation and international clinical partnerships.

Swiss Medical Network joins Mayo Clinic Care Network to elevate patient care

13 May 2025

Neuchâtel’s CSEM is playing a central role in the QUESTIONED project, an initiative aiming to reduce postoperative delirium (POD) in elderly patients through real-time brain activity monitoring during anesthesia.

CSEM technology supports breakthrough in EEG monitoring to reduce postoperative delirium

12 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

1 2 3 4 5 6 … 43